Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Bürgisser, Philippe; Garzoni, Christian; Hirschel, Bernard; Cavassini, Matthias; Battegay, Manuel; Vernazza, Pietro L; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F; Swiss HIV Cohort Study (SHCS), (2011). Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. Journal of acquired immune deficiency syndromes JAIDS, 57(1), pp. 24-31. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e318211925e
Full text not available from this repository. (Request a copy)Nucleoside reverse transcriptase inhibitors (NRTIs) are often administered in salvage therapy even if genotypic resistance tests (GRTs) indicate high-level resistance, but little is known about the benefit of these additional NRTIs.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Garzoni, Christian |
ISSN: |
0894-9255 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:24 |
Last Modified: |
05 Dec 2022 14:07 |
Publisher DOI: |
10.1097/QAI.0b013e318211925e |
PubMed ID: |
21283013 |
Web of Science ID: |
000289509100010 |
URI: |
https://boris.unibe.ch/id/eprint/8278 (FactScience: 213795) |
Actions (login required)
 |
Edit item |